• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Carl-Magnus Rudenstam, David Zahrieh, +11 authors Alan S. Coates
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2006
  • PURPOSE Axillary clearance in early breast cancer aims to improve locoregional control and provide staging information but is associated with undesirable morbidity. We therefore investigated whetherContinue Reading
  • Bernhard Cornelius Pestalozzi, David Zahrieh, +12 authors Aron Goldhirsch
  • Medicine
  • Annals of oncology : official journal of the…
  • 2006 (First Publication: 1 June 2006)
  • BACKGROUND We sought to determine whether a high-risk group could be defined among patients with operable breast cancer in whom a search of occult central nervous system (CNS) metastases wasContinue Reading
  • Elisabeth Kenne Sarenmalm, Lena B Mårtensson, Stig B. Holmberg, Bengt A. Andersson, Anders Odén, Ingrid H E Bergh
  • Medicine
  • BMC Complementary and Alternative Medicine
  • 2013 (First Publication: 1 December 2013)
  • BackgroundThe stress of a breast cancer diagnosis and its treatment can produce a variety of psychosocial sequelae including impaired immune responses. Mindfulness Based Stress Reduction (MBSR) is aContinue Reading
  • Peter Naredi, P G Lindnér, Stig B. Holmberg, Unne Stenram, Alan E. Peterson, Larsolof R. Hafström
  • Medicine
  • International journal of cancer
  • 1993 (First Publication: 19 June 1993)
  • The influence of TNF alpha on tumour growth rate has been attributed to its effects on the vascular bed and blood flow. The aim of our study was to investigate the effects of pharmacological doses ofContinue Reading
  • Per Edlund, Johan Ahlgren, +9 authors Carl Blomqvist
  • Medicine
  • Acta oncologica
  • 2011 (First Publication: 1 April 2011)
  • UNLABELLED The SBG 2000-1 trial is a randomised study that investigates if dose-tailored adjuvant FEC therapy based on the individual's leukocyte nadir value can improve outcome. The study hasContinue Reading
  • Marco Colleoni, Shari I Gelber, +7 authors Alan S. Coates
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2004
  • 532 Background: The value of 5 years of Tam in premenopausal women with breast cancer and its benefit according to endocrine responsiveness of the tumor has not been completely defined. METHODSContinue Reading